<i>In Vitro</i> Activity of Novel Topoisomerase Inhibitors against <i>Francisella tularensis</i> and <i>Burkholderia pseudomallei</i>
Antimicrobial resistance is a global issue, and the investigation of alternative therapies that are not traditional antibiotics are warranted. Novel bacterial type II topoisomerase inhibitors (NBTIs) have recently emerged as a novel class of antibiotics with reduced potential for cross-resistance to...
Saved in:
Main Authors: | Adam O. Whelan (Author), Ian Cooper (Author), Nicola Ooi (Author), David Orr (Author), Kevin Blades (Author), James Kirkham (Author), Amanda Lyons (Author), Kay B. Barnes (Author), Mark I. Richards (Author), Anne-Marie Salisbury (Author), Mark Craighead (Author), Sarah V. Harding (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of <i>dipA</i> and <i>pilD</i> in <i>Francisella tularensis</i> Susceptibility to Resazurin
by: Kendall Souder, et al.
Published: (2021) -
An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational <i>Burkholderia pseudomallei</i>
by: Thomas R. Laws, et al.
Published: (2022) -
The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized <i>Burkholderia pseudomallei</i>
by: Michelle Nelson, et al.
Published: (2023) -
Efficacy of Treatment with the Antibiotic Novobiocin against Infection with <i>Bacillus anthracis</i> or <i>Burkholderia pseudomallei</i>
by: Christopher P. Klimko, et al.
Published: (2022) -
In Vitro Antimicrobial Susceptibilities of <i>Francisella tularensis</i> subsp. <i>holarctica</i> Isolates from Tularemia Outbreaks That Occurred from the End of the 20th Century to the 2020s in Spain
by: Sonia Martínez-Martínez, et al.
Published: (2021)